Aluminio en pacientes con terapia de reemplazo renal crónico con hemodiálisis en dos unidades renales en bogotá

Abstract

Objective Determining aluminium concentrations in the serum of patients undergoing chronic renal replacement therapy with haemodialysis and concentration in distribution network water and dialysis in two renal units in Bogotá. Material and Methods This was a descriptive study of 63 haemodialysed patients and 20 healthy subjects. Aluminium concentration was determined in water and serum using graphite furnace atomic absorption spectrometry with deuterium lamp background corrector. Results Average aluminium concentration was 26.5 μg/L in patients (ranging from 11.2 to 49.2 μg/L; 8.03 standard deviation) and 8.05 μg/L in healthy individuals (ranging from undetectable to 17.2 μg/L; 4.31 standard deviation). Aluminium concentration in dialysis water and distribution network water was below 2 μg/L and 200 μg/L, respectively. Conclusions Aluminium concentration in water and serum in this study was below international standard values, thereby indicating appropriate treatment. Additionally, aluminium concentration in pre-HD and post-HD sera was below that reported previously. Aluminium hydroxide uptake increases aluminium concentration in serum. Personal situation regarding age, gender, civil and work status were not risk factors determining aluminium concentrations in serum.